James Bethell
Showing 1–3 of 3 transcripts.
- Milken Institute44 min
Building Smart Health Ecosystems: Shaping the Future of Health Care | Middle East and Africa Summit
James Bethell, Helmy Eltoukhy, Helmut Schuehsler, Geetha Tharmaratnam
Healthcare panelists identify the transition to patient-centric smart ecosystems as essential for shifting from reactive symptom treatment to proactive, personalized prevention, yet they note that entrenched fee-for-service models in Western markets like the US currently impede the adoption of existing clinical guidelines. While immediate gains are achievable through strict implementation of current protocols and breakthroughs like FDA-approved liquid biopsies, radical transformation is projected to occur most rapidly in emerging markets such as the Middle East and Africa where legacy infrastructure is absent. To overcome funding gaps and scale these innovations globally, experts advocate for the development of unified regulatory frameworks and the mobilization of patient capital from multilateral institutions to support long-term health infrastructure projects.
- Milken Institute15 min
Conversation with Health Dept Chairman HE Mansoor Ibrahim Al Mansoori | Middle East & Africa Summit
HE Mansoor Ibrahim Al Mansoori, His Excellency Mansoor Ibrahim Al Mansoori, James Bethell
The Abu Dhabi Department of Health is executing a strategic pivot from reactive sick care to proactive health management by integrating a unified data lake, the Malafi system, and a population-scale genomic program to predict and prevent non-communicable diseases. Under the leadership of Chairman Al Mansouri, this initiative combines artificial intelligence training for medical staff with the establishment of a licensed longevity clinic to optimize individual biology through lifestyle interventions. Backed by direct presidential support, the strategy aims to extend healthy lifespans and reduce long-term healthcare costs by addressing the 80% of health determinants derived from external factors rather than just treating medical symptoms.
- Milken Institute59 min
Longevity Lab: Can You Live to 100? | Global Conference 2024
Allison Aubrey, James Bethell, Dan Buettner, Peter Diamandis, Kristen Fortney, Lloyd Minor
A panel of scientists and policymakers discusses converging strategies to achieve longevity escape velocity through the integration of AI-driven biotech, emerging drugs like rapamycin and GLP-1 agonists, and preventative Blue Zone principles that emphasize environmental design over individual willpower. With the XPRIZE Healthspan Competition challenging teams to reverse functional aging within a decade and healthcare systems pivoting from sick care to community-based prevention, the dialogue highlights a transition toward treating aging as a manageable biological process rather than an inevitable decline. While optimistic projections suggest widespread adoption of anti-aging therapies within twenty years, experts caution that true success requires balancing pharmacological interventions with social determinants of health to ensure extended healthspan alongside increased lifespan.